Lenalidomide Grindeks (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4‑CRBN E3 ubiquitin ligase complex. This binding changes the complex’s target proteins, leading to the degradation of transcription factors Ikaros and Aiolos. The result is reduced tumor cell proliferation, inhibition of new blood‑vessel formation, and modulation of the immune response against malignant cells.

The specific dose of Lenalidomide Grindeks is determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other individual factors. Healthcare professionals follow approved labeling and clinical guidelines to set an appropriate regimen for each patient.

Lenalidomide is classified as pregnancy category X because it can cause severe birth defects. It is contraindicated in pregnancy, and effective contraception is required for both male and female patients of reproductive potential. Breastfeeding is not recommended while taking lenalidomide, as the drug may be excreted in milk.

To request Lenalidomide Grindeks, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and necessary import documentation.

Lenalidomide belongs to the immunomodulatory drug class, offering a distinct mechanism compared with proteasome inhibitors or monoclonal antibodies. It provides oral administration, anti‑angiogenic activity, and immune‑enhancing effects, often used in combination with dexamethasone or other agents to achieve synergistic disease control.

Lenalidomide Grindeks should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and store it out of reach of children to maintain potency and safety.

Lenalidomide Grindeks is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Dosing schedules vary, and patients should follow the prescriber’s instructions regarding timing and any required food restrictions.

The most serious risks include thromboembolic events such as deep‑vein thrombosis, severe neutropenia that can predispose to infections, hepatotoxicity, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored regularly for signs of these complications and report any concerning symptoms promptly.

Lenalidomide Grindeks should not be used by individuals who are pregnant, planning to become pregnant, or not using reliable contraception. It is also contraindicated in patients with known hypersensitivity to lenalidomide or any component of the formulation, and caution is advised in those with severe renal or hepatic impairment.